APA (7th ed.) Citation

DIAGO, M., OLVEIRA, A., SOLÁ, R., ROMERO‐GÓMEZ, M., MORENO‐OTERO, R., PÉREZ, R., . . . GARIJO, J. M. (2007). Treatment of chronic he1patitis C genotype 1 with peginterferon- α2a (40 kDa) plus ribavirin under routine clinical practice in Spain: Early prediction of sustained virological response rate. Alimentary Pharmacology & Therapeutics, 25(8), 899. https://doi.org/10.1111/j.1365-2036.2007.03270.x

Chicago Style (17th ed.) Citation

DIAGO, M., et al. "Treatment of Chronic He1patitis C Genotype 1 with Peginterferon- α2a (40 KDa) Plus Ribavirin Under Routine Clinical Practice in Spain: Early Prediction of Sustained Virological Response Rate." Alimentary Pharmacology & Therapeutics 25, no. 8 (2007): 899. https://doi.org/10.1111/j.1365-2036.2007.03270.x.

MLA (9th ed.) Citation

DIAGO, M., et al. "Treatment of Chronic He1patitis C Genotype 1 with Peginterferon- α2a (40 KDa) Plus Ribavirin Under Routine Clinical Practice in Spain: Early Prediction of Sustained Virological Response Rate." Alimentary Pharmacology & Therapeutics, vol. 25, no. 8, 2007, p. 899, https://doi.org/10.1111/j.1365-2036.2007.03270.x.